-
2
-
-
0028978780
-
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an intergroup rhabdomyosarcoma study
-
Newton WA Jr, Gehan EA, Webber BL, et al . Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an intergroup rhabdomyosarcoma study. Cancer 1995;76:1073-85.
-
(1995)
Cancer
, vol.76
, pp. 1073-1085
-
-
Newton Jr., W.A.1
Gehan, E.A.2
Webber, B.L.3
-
3
-
-
33748474046
-
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: The children's oncology group
-
DOI 10.1200/JCO.2005.05.3801
-
Meza JL, Anderson J, Pappo AS, et al . Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. J Clin Oncol 2006;24:3844-51. (Pubitemid 46630730)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.24
, pp. 3844-3851
-
-
Meza, J.L.1
Anderson, J.2
Pappo, A.S.3
Meyer, W.H.4
-
4
-
-
77952583590
-
Outcomes in paediatric metastatic rhabdomyosarcoma: Results of The International Society of Paediatric Oncology (SIOP) study MMT-98
-
McDowell HP, Foot AB, Ellershaw C, et al. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. Eur J Cancer 2010;46:1588-95.
-
(2010)
Eur J Cancer
, vol.46
, pp. 1588-1595
-
-
McDowell, H.P.1
Foot, A.B.2
Ellershaw, C.3
-
5
-
-
33745587303
-
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
-
DOI 10.1073/pnas.0603507103
-
Kasprzycka M, Marzec M, Liu X, et al. Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. Proc Natl Acad Sci USA 2006;103:9964-9. (Pubitemid 43993606)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.26
, pp. 9964-9969
-
-
Kasprzycka, M.1
Marzec, M.2
Liu, X.3
Zhang, Q.4
Wasik, M.A.5
-
6
-
-
0034672140
-
Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
-
Bai RY, Ouyang T, Miething C, et al. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Blood 2000;96:4319-27.
-
(2000)
Blood
, vol.96
, pp. 4319-4327
-
-
Bai, R.Y.1
Ouyang, T.2
Miething, C.3
-
7
-
-
34249324494
-
An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
-
DOI 10.1158/0008-5472.CAN-06-4443
-
Zou HY, Li Q, Lee JH, et al. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res 2007;67:4408-17. (Pubitemid 46815090)
-
(2007)
Cancer Research
, vol.67
, Issue.9
, pp. 4408-4417
-
-
Zou, H.Y.1
Li, Q.2
Lee, J.H.3
Arango, M.E.4
McDonnell, S.R.5
Yamazaki, S.6
Koudriakova, T.B.7
Alton, G.8
Cui, J.J.9
Kung, P.-P.10
Nambu, M.D.11
Los, G.12
Bender, S.L.13
Mroczkowski, B.14
Christensen, J.G.15
-
8
-
-
0036734911
-
Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases
-
Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002;15:931-8.
-
(2002)
Mod Pathol
, vol.15
, pp. 931-938
-
-
Cessna, M.H.1
Zhou, H.2
Sanger, W.G.3
-
9
-
-
78651062586
-
Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer
-
Salido M, Pijuan L, Martinez-Aviles L, et al. Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer. J Thorac Oncol 2011;6:21-7.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 21-27
-
-
Salido, M.1
Pijuan, L.2
Martinez-Aviles, L.3
-
10
-
-
77956244494
-
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
-
De Brouwer S, De Preter K, Kumps C, et al. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin Cancer Res 2010;16:4353-62.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4353-4362
-
-
De Brouwer, S.1
De Preter, K.2
Kumps, C.3
-
11
-
-
84855993158
-
Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: Clinical and prognostic implications
-
van Gaal JC, Flucke UE, Roeffen MH, et al. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. J Clin Oncol 2012;30:308-15.
-
(2012)
J Clin Oncol
, vol.30
, pp. 308-315
-
-
Van Gaal, J.C.1
Flucke, U.E.2
Roeffen, M.H.3
-
12
-
-
3042811150
-
Expression of anaplastic lymphoma kinase in soft tissue tumors: An immunohistochemical and molecular study of 249 cases
-
DOI 10.1016/j.humpath.2003.12.004, PII S0046817704000383
-
Li XQ, Hisaoka M, Shi DR, et al. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Hum Pathol 2004;35:711-21. (Pubitemid 38881081)
-
(2004)
Human Pathology
, vol.35
, Issue.6
, pp. 711-721
-
-
Li, X.-Q.1
Hisaoka, M.2
Shi, D.-R.3
Zhu, X.-Z.4
Hashimoto, H.5
-
13
-
-
78049425319
-
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
-
Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363:1693-703.
-
(2010)
N Engl J Med
, vol.363
, pp. 1693-1703
-
-
Kwak, E.L.1
Bang, Y.J.2
Camidge, D.R.3
-
14
-
-
78049428879
-
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor
-
Butrynski JE, D'Adamo DR, Hornick JL, et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010;363:1727-33.
-
(2010)
N Engl J Med
, vol.363
, pp. 1727-1733
-
-
Butrynski, J.E.1
D'Adamo, D.R.2
Hornick, J.L.3
-
15
-
-
10944236359
-
Pathology and genetics of tumours of soft tissue and bone
-
Christopher D.M. Flecther, K. Krishnan Unni, Fredrik Mertens, eds. France: IARC Press
-
Fletcher CDM, Mertens F. Pathology and genetics of tumours of soft tissue and bone. In: Christopher D.M. Flecther, K. Krishnan Unni, Fredrik Mertens, eds. World Health Organization classification of tumours. France: IARC Press, 2002:146-52.
-
(2002)
World Health Organization Classification of Tumours
, pp. 146-152
-
-
Fletcher, C.D.M.1
Mertens, F.2
-
16
-
-
0031055562
-
Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
-
Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997;89:1394-404. (Pubitemid 27080004)
-
(1997)
Blood
, vol.89
, Issue.4
, pp. 1394-1404
-
-
Pulford, K.1
Lamant, L.2
Morris, S.W.3
Butler, L.H.4
Wood, K.M.5
Stroud, D.6
Delsol, G.7
Mason, D.Y.8
-
17
-
-
70149119168
-
ALK expression in rhabdomyosarcomas: Correlation with histologic subtype and fusion status
-
Corao DA, Biegel JA, Coffin CM, et al. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status. Pediatr Dev Pathol 2009;12:275-83.
-
(2009)
Pediatr Dev Pathol
, vol.12
, pp. 275-283
-
-
Corao, D.A.1
Biegel, J.A.2
Coffin, C.M.3
-
18
-
-
81055126433
-
Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma
-
Bresler SC, Wood AC, Haglund EA, et al. Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Sci Transl Med 2011;3:108ra114.
-
(2011)
Sci Transl Med
, vol.3
-
-
Bresler, S.C.1
Wood, A.C.2
Haglund, E.A.3
-
19
-
-
84895063022
-
ALK amplification and crizotinib sensitivity in non-small cell lung cancer cell lines and patients report
-
abstract
-
Kalai Khadija NA, Lueza B, Commo F, et al. ALK amplification and crizotinib sensitivity in non-small cell lung cancer cell lines and patients report [abstract]. J Clin Oncol 2012;30(Suppl 10556). http://meetinglibrary. asco.org/content/ 98912-114
-
(2012)
J Clin Oncol
, vol.30
, Issue.SUPPL. 10556
-
-
Kalai Khadija, N.A.1
Lueza, B.2
Commo, F.3
|